November 5, 2024. Exyte, a global leader in the design, engineering and supply of high-tech equipment, has successfully completed the acquisition of TTP Group (“TTP”). The transaction, announced in September 2024, has been completed following receipt of all necessary regulatory approvals.
Categories
Tags
Contact info
Silicon Saxony
Marketing, Kommunikation und Ă–ffentlichkeitsarbeit
Manfred-von-Ardenne-Ring 20 F
Fax: +49 351 8925 889
Contact person:
TTP is a specialized and recognized partner for blue-chip customers in the biotechnology, pharmaceutical and chemical sectors in Europe. With its operating brands “Pharmaplan” and “Triplan”, the company covers the entire service spectrum, from engineering to procurement, construction management and validation.
Exyte will combine TTP with its own biopharma and life sciences activities in Europe to build an even closer partnership with the fast-growing European biotech and pharma sectors. The transaction consolidates Exyte’s position as a global player in the pharmaceutical market, strengthening both the company’s presence and capabilities in Europe.
Dr. Wolfgang BĂĽchele, CEO of Exyte, said: “This strategic move is an important milestone for Exyte on our ‘Pathway to Ten’ and is in line with our ‘Next Level’ future agenda. The combination of TTP’s engineering competence with Exyte’s expertise in project realization strengthens our presence in the European biotech and pharma sector. We can now offer our customers comprehensive support, from strategic planning to the realization of technically complex plants.”
Dr. Andreas Bonhoff, CEO of TTP Group, explains: “TTP and Exyte share the ambition to offer innovative and sustainable solutions. Together we will expand our position in the growing market for pharmaceutical and chemical plants. The combination of our strengths is a win-win for our customers and a positive step towards a successful future.”
The Biopharma and Life Sciences Global Business Unit, led by President Ronan Donohue, is Exyte’s second largest segment by revenue. The unit’s revenue reached 580 million euros in 2023. Incoming orders rose by 12 percent to 650 million euros. As part of the “Next Level” agenda, sales in Biopharma and Life Sciences are set to increase further. In the medium term, the division plans to achieve sales of more than 1.5 billion euros. Donohue says: “The combination of TTP with our current European Biopharma and Life Sciences organization is a key accelerator for the growth of the Global Business Unit.”
Exyte is a global leader in the design, engineering and supply of ultra-clean and sustainable equipment for the high-tech industry. With its unique expertise, which the company has been continuously developing for over a century, Exyte supplies customers in the highly complex semiconductor, battery cell, pharmaceutical, biotechnology and data center industries. Exyte offers its customers worldwide a comprehensive range of services – from consulting to the implementation of turnkey solutions in compliance with the highest safety and quality standards. The company creates a better future by enabling key industries to improve the quality of modern life. In 2023, Exyte generated a turnover of 7.1 billion euros with around 9,900 employees worldwide.
TTP Group is a group of companies specializing in engineering services for the process industry. More than 1,000 employees work at 27 locations in Belgium, Germany, France, Austria and Switzerland under the operating brands Pharmaplan and Triplan. Pharmaplan covers the entire value chain of pharmaceutical engineering, from consulting to the implementation of EPCM projects, qualification and validation as well as upgrades and local site support. As a leading engineering partner for the chemical industry, Triplan takes on the technical development of new and conversion projects as well as the modernization of existing plants. With its two strong brands, which have been established for over 50 years, the TTP Group is one of the leading engineering service providers in Europe.
Further links
👉 www.exyte.net
👉 www.ttp-group.eu
Photo: Unsplash
